Anil Menon, a Nasa astronaut of Indian origin, has embarked on one of the most scientifically significant long-duration missions aboard the International Space Station (ISS). Launched on July 14 aboard the Soyuz MS-29 spacecraft from the Baikonur Cosmodrome in Kazakhstan, Menon will spend approximately eight months living and working aboard the orbital laboratory as a Flight Engineer for Expeditions 74 and 75 alongside Roscosmos cosmonauts Pyotr Dubrov and Anna Kikina. While every astronaut contributes to station operations and scientific investigations, Menon's unique background as an emergency medicine physician, NASA flight surgeon, former Medical Director at SpaceX, mechanical engineer, and Colonel in the U.S. Space Force makes his mission particularly significant for the future of space medicine.
Unlike shorter missions lasting only a few weeks, an eight-month stay provides scientists with a rare opportunity to observe how the human body continuously adapts to prolonged exposure to microgravity. Understanding these physiological changes has become one of NASA's highest priorities as humanity prepares to establish a sustained presence on the Moon under the Artemis missions and eventually undertake multi-year expeditions to Mars. Every day spent aboard the ISS provides invaluable medical data that cannot be reproduced in laboratories on Earth.
“The absence of gravity fundamentally alters nearly every biological system within the human body. Within hours of entering orbit, body fluids begin shifting from the lower limbs toward the upper body and head, producing changes in cardiovascular function, blood circulation, intracranial pressure, and vision. Over weeks and months, astronauts experience gradual muscle atrophy, accelerated bone mineral loss, alterations in immune function, metabolic changes, hormonal fluctuations, sleep disturbances, and modifications in cellular activity. In many respects, long-duration spaceflight mimics an accelerated model of human ageing, allowing scientists to investigate biological processes that would normally take decades to unfold on Earth,” explained Srimathy Kesan, the founder and CEO of SpaceKidz, a Chennai-based space company.
Throughout his mission, Menon will contribute to comprehensive investigations examining cardiovascular physiology, vascular adaptation, blood chemistry, neurological responses, musculo-skeletal health, endocrine regulation, metabolism, and immune function. Using sophisticated biomedical sensors, wearable monitoring systems, ultrasound imaging, laboratory diagnostics, and continuous physiological measurements, researchers are building the most detailed picture yet of how the human body responds to extended periods in space. These investigations are not only essential for protecting astronauts but also provide important insights into cardiovascular disease, osteoporosis, muscle degeneration, ageing, rehabilitation medicine, and prolonged immobilisation among patients on Earth.
“One of the most remarkable aspects of Menon's mission is its emphasis on the future of autonomous space medicine. Future astronauts travelling to Mars will not have the luxury of immediate communication with physicians on Earth. Communication delays of up to 20 minutes each way will require crews to diagnose illnesses, perform medical procedures, and manage emergencies independently. The (ISS) therefore serves as the world's premier testbed for developing portable diagnostic equipment, wearable health-monitoring systems, digital medical technologies, point-of-care laboratory devices, and intelligent healthcare systems capable of supporting autonomous medical care far from Earth. Many of these innovations are expected to revolutionise telemedicine, emergency healthcare, disaster response, military medicine, and healthcare delivery in remote communities across the globe,” added Kesan.
Experts point out that among the most innovative medical technology demonstrations during the expedition is the evaluation of systems capable of producing sterile intravenous (IV) fluids directly aboard the ISS using its sophisticated water recovery system. Carrying large quantities of IV fluids for long-duration missions is neither practical nor economical because of launch mass limitations and finite shelf life. By demonstrating the capability to manufacture medical-grade IV solutions whenever required, astronauts can become significantly more self-sufficient during future lunar and Martian expeditions. Beyond space exploration, this technology could transform emergency medicine by enabling rapid production of sterile fluids in disaster zones, military operations, humanitarian missions, and isolated healthcare facilities.
Another major focus of biomedical research aboard the ISS is understanding how microgravity influences the immune system at both the cellular and molecular levels. Scientists are investigating how prolonged spaceflight affects immune cell function, inflammatory responses, tissue repair, microbial behaviour, and cellular metabolism. These studies may reveal entirely new mechanisms underlying ageing, autoimmune disorders, infection control, regenerative medicine, and chronic inflammatory diseases. Every biological sample collected during Menon's mission contributes to one of the world's largest ongoing investigations into human adaptation beyond Earth's gravity.
“Menon's mission also supports numerous investigations extending well beyond medicine. The ISS provides an unparalleled environment for materials science, biotechnology, semiconductor manufacturing, fluid dynamics, combustion science, robotics, and advanced engineering research,” remarked Kesan.
In microgravity, crystals grow with exceptional structural uniformity because they are not disturbed by gravity-driven convection or sedimentation. These nearly perfect crystals may enable breakthroughs in semiconductor manufacturing, quantum technologies, pharmaceutical development, advanced medical imaging systems, and next-generation computing. Similarly, studies in fluid physics and materials engineering are helping scientists design safer spacecraft, more efficient life-support systems, and advanced manufacturing techniques that could one day support permanent human settlements beyond Earth.
Although scientific research forms the core of the mission, life aboard the International Space Station demands far more than conducting experiments. Each day, astronauts spend hours maintaining station systems, operating scientific payloads, supporting cargo and crew spacecraft, repairing equipment, installing new research hardware, collecting experimental data, participating in educational outreach, and exercising for nearly two hours to counteract muscle and bone loss. Every activity contributes to ensuring that the ISS remains a continuously operating scientific laboratory capable of supporting dozens of simultaneous investigations from researchers around the world.
Few astronauts possess a professional background as uniquely suited to this environment as Anil Menon. Before joining NASA's astronaut corps, he conducted neurobiology research at Harvard University, earned both a Master of Science in Mechanical Engineering and a Doctor of Medicine degree from Stanford University, served as a NASA flight surgeon supporting astronauts on the ISS worked as Medical Director at SpaceX developing medical protocols for commercial human spaceflight, and served as a Colonel in the United States Space Force. His multidisciplinary expertise allows him to bridge clinical medicine, aerospace engineering, operational healthcare, and human performance, making him exceptionally qualified to contribute to the next generation of biomedical research in space.
